Creatine and GLP-1: Protecting Muscle During Weight Loss

Creatine used to be a supplement for bodybuilders. That framing is outdated.

In 2026, creatine monohydrate has been described by researchers as a "global health supplement" - with evidence spanning muscle preservation, cognitive performance, and bone density. For GLP-1 users specifically, it may be one of the most under-utilised tools available.

What Creatine Does

Creatine monohydrate works by increasing the availability of phosphocreatine in muscle cells - the molecule used to regenerate ATP (adenosine triphosphate), the primary energy currency of muscle contraction. More phosphocreatine means more capacity for short, intense effort, faster recovery between sets, and (critically) a more robust signal for muscle protein synthesis.

In practical terms, this translates to:

• Greater strength gains from the same resistance training programme
• Faster recovery between sessions
• Meaningful preservation of lean mass during caloric restriction
• Cognitive benefits - creatine is also stored and used in the brain; supplementation supports memory, processing speed, and mental fatigue resistance
• Bone density support - emerging evidence links creatine to improvements in bone mineral content, particularly when combined with resistance training

For GLP-1 users, the lean mass preservation and bone density angles are directly relevant to the most significant risks of rapid pharmaceutical weight loss.

The Evidence Base

Creatine monohydrate has one of the most robust safety and efficacy profiles in sports nutrition science — with over 1,000 peer-reviewed studies. A 2025 systematic review from the Journal of the International Society of Sports Nutrition (JISSN) confirmed the combination of creatine with resistance training produces superior lean mass and strength outcomes compared to resistance training alone.

For older adults specifically — a population at elevated GLP-1 muscle loss risk — the evidence is particularly compelling. Multiple randomised controlled trials have demonstrated that creatine supplementation (3–5g daily) combined with resistance training produces meaningful improvements in muscle mass, strength, and functional capacity in adults over 50. The ACLM/ASN joint advisory (American Journal of Clinical Nutrition, April 2026) lists resistance training as essential; creatine is the nutritional complement that maximises the return on that investment.

On bone density: a Current Nutrition Reports review (2025) on GLP-1s in older adults noted the elevated fracture risk in this population. Several trials have found creatine supplementation increases bone mineral content independently of its muscle effects — a dual-action benefit that is uniquely valuable for users already at GLP-1-related bone loss risk.

How Much and When

Dose: 3–5g of creatine monohydrate daily. No loading phase is necessary - the traditional "loading phase" of 20g/day for a week produces faster saturation but the same long-term result as a steady 5g daily. Given that GLP-1 users often have sensitive GI systems, a steady low dose is preferable.

Timing: Post-workout is generally considered slightly superior to pre-workout, based on evidence that insulin-mediated creatine uptake is enhanced in the post-exercise window when muscle is more insulin-sensitive. However, consistency matters more than precise timing - taking it at the same time daily is more important than taking it at the "perfect" moment. Mixing it into a post-workout protein shake is a practical solution.

Form: Creatine monohydrate is the only form with a robust evidence base. More expensive forms (creatine ethyl ester, buffered creatine, creatine HCl) have not demonstrated superior outcomes in head-to-head trials. Save your money.

With water: Creatine draws water into muscle cells. GLP-1 users are already at elevated dehydration risk. Ensure you're drinking adequate fluids (with electrolytes) on days you supplement. Some users notice minor bloating in the first week - this resolves.

Safety on GLP-1 Medications

Creatine monohydrate is safe for healthy kidneys. The concern about kidney strain is a persistent myth from early and flawed research. A comprehensive 2021 review confirmed no adverse kidney effects from long-term creatine supplementation in healthy individuals. If you have pre-existing kidney disease, discuss with your doctor before starting.

There are no known interactions between creatine and GLP-1 receptor agonists. They operate through entirely different mechanisms and do not interfere with each other.

The Case, Simply Put

You are on a medication that, without active countermeasures, will take some of your lean mass along with your fat. Creatine, combined with resistance training and adequate protein, is one of the most evidence-supported ways to ensure the lean mass that remains is functional, strong, and metabolically active.

It's cheap. It's safe. It works. It dissolves in water. There are very few supplements that earn all four of those descriptors simultaneously.

Disclaimer: This article is for educational purposes only. Consult your healthcare provider before starting any new supplement, particularly if you have existing kidney or liver conditions.

References

1. The Metabolic Recomposition Revolution: GLP-1, Creatine and Lean Mass. Culinary Creations Wellness. Mar 2026. https://wellness.culinarycreationss.com/blog/the-metabolic-recomposition-revolution-beyond-the-scale-in-the-age-of-glp-1
2. Mozaffarian D, et al. Nutritional Priorities to Support GLP-1 Therapy for Obesity: Joint Advisory. American Journal of Clinical Nutrition. Apr 2026. https://www.sciencedirect.com/science/article/pii/S0002916525002400
3. Creatine Timing and Resistance Training Adaptations. ClinicalTrials.gov. NCT03678857. https://clinicaltrials.gov/study/NCT03678857
4. Nutrient Timing: A Garage Door of Opportunity? PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400400/
5. GLP-1 Muscle Loss: Your 2026 Metabolic Recomposition Guide. Culinary Creations Wellness. https://wellness.culinarycreationss.com/blog/the-metabolic-recomposition-revolution-beyond-the-scale-in-the-age-of-glp-1